These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28202529)

  • 21. TSC2 modulates cell adhesion and migration via integrin-α1β1.
    Moir LM; Black JL; Krymskaya VP
    Am J Physiol Lung Cell Mol Physiol; 2012 Oct; 303(8):L703-10. PubMed ID: 22923640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.
    Giannikou K; Malinowska IA; Pugh TJ; Yan R; Tseng YY; Oh C; Kim J; Tyburczy ME; Chekaluk Y; Liu Y; Alesi N; Finlay GA; Wu CL; Signoretti S; Meyerson M; Getz G; Boehm JS; Henske EP; Kwiatkowski DJ
    PLoS Genet; 2016 Aug; 12(8):e1006242. PubMed ID: 27494029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endothelium.
    Issaka RB; Oommen S; Gupta SK; Liu G; Myers JL; Ryu JH; Vlahakis NE
    Am J Pathol; 2009 Oct; 175(4):1410-20. PubMed ID: 19717640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SRC kinase is a novel therapeutic target in lymphangioleiomyomatosis.
    Tyryshkin A; Bhattacharya A; Eissa NT
    Cancer Res; 2014 Apr; 74(7):1996-2005. PubMed ID: 24691995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
    Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
    Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prolactin on TSC2-null Eker rat cells and in pulmonary lymphangioleiomyomatosis.
    Terasaki Y; Yahiro K; Pacheco-Rodriguez G; Steagall WK; Stylianou MP; Evans JF; Walker AM; Moss J
    Am J Respir Crit Care Med; 2010 Aug; 182(4):531-9. PubMed ID: 20413627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses.
    Hayashi T; Kumasaka T; Mitani K; Okada Y; Kondo T; Date H; Chen F; Oto T; Miyoshi S; Shiraishi T; Iwasaki A; Hara K; Saito T; Ando K; Kobayashi E; Gunji-Niitsu Y; Kunogi M; Takahashi K; Yao T; Seyama K
    Hum Pathol; 2016 Apr; 50():34-42. PubMed ID: 26997436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberous sclerosis complex 2 loss increases lysophosphatidylcholine synthesis in lymphangioleiomyomatosis.
    Priolo C; Ricoult SJ; Khabibullin D; Filippakis H; Yu J; Manning BD; Clish C; Henske EP
    Am J Respir Cell Mol Biol; 2015 Jul; 53(1):33-41. PubMed ID: 25780943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway.
    Makovski V; Jacob-Hirsch J; Gefen-Dor C; Shai B; Ehrlich M; Rechavi G; Kloog Y
    Cell Death Dis; 2014 Dec; 5(12):e1557. PubMed ID: 25476905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphangioleiomyomatosis: a metastatic lung disease.
    Kundu N; Holz MK
    Am J Physiol Cell Physiol; 2023 Feb; 324(2):C320-C326. PubMed ID: 36571446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis.
    Pacheco-Rodriguez G; Steagall WK; Crooks DM; Stevens LA; Hashimoto H; Li S; Wang JA; Darling TN; Moss J
    Cancer Res; 2007 Nov; 67(21):10573-81. PubMed ID: 17975002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutaredoxin-1 promotes lymphangioleiomyomatosis progression through inhibiting Bim-mediated apoptosis via COX2/PGE2/ERK pathway.
    Feng Y; Li T; Li Y; Lin Z; Han X; Pei X; Zhang Y; Li F; Yang J; Shao D; Li C
    Clin Transl Med; 2023 Jul; 13(7):e1333. PubMed ID: 37478294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic rearrangements in sporadic lymphangioleiomyomatosis: an evolving genetic story.
    Murphy SJ; Terra SB; Harris FR; Nasir A; Voss JS; Smadbeck JB; Johnson SH; Serla V; Ryu JH; Yi ES; Kipp BR; Vasmatzis G; Carmona EM
    Mod Pathol; 2017 Sep; 30(9):1223-1233. PubMed ID: 28643793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autophagy: an 'Achilles' heel of tumorigenesis in TSC and LAM.
    Yu J; Parkhitko A; Henske EP
    Autophagy; 2011 Nov; 7(11):1400-1. PubMed ID: 21997371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ETV2 regulates PARP-1 binding protein to induce ER stress-mediated death in tuberin-deficient cells.
    Shrestha S; Lamattina A; Pacheco-Rodriguez G; Ng J; Liu X; Sonawane A; Imani J; Qiu W; Kosmas K; Louis P; Hentschel A; Steagall WK; Onishi R; Christou H; Henske EP; Glass K; Perrella MA; Moss J; Tantisira K; El-Chemaly S
    Life Sci Alliance; 2022 May; 5(5):. PubMed ID: 35181635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycoprotein non-metastatic melanoma protein B promotes tumor growth and is a biomarker for lymphangioleiomyomatosis.
    Gibbons E; Taya M; Wu H; Lopa SH; Moss J; Henske EP; McCormack FX; Hammes SR
    Endocr Relat Cancer; 2024 Jun; 31(6):. PubMed ID: 38614127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by deep sequencing.
    Fujita A; Ando K; Kobayashi E; Mitani K; Okudera K; Nakashima M; Miyatake S; Tsurusaki Y; Saitsu H; Seyama K; Miyake N; Matsumoto N
    Hum Genet; 2016 Jan; 135(1):61-8. PubMed ID: 26563443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence Supporting a Lymphatic Endothelium Origin for Angiomyolipoma, a TSC2(-) Tumor Related to Lymphangioleiomyomatosis.
    Yue M; Pacheco G; Cheng T; Li J; Wang Y; Henske EP; Schuger L
    Am J Pathol; 2016 Jul; 186(7):1825-1836. PubMed ID: 27289491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TSC2 Interacts with HDLBP/Vigilin and Regulates Stress Granule Formation.
    Kosmas K; Filippakis H; Khabibullin D; Turkiewicz M; Lam HC; Yu J; Kedersha NL; Anderson PJ; Henske EP
    Mol Cancer Res; 2021 Aug; 19(8):1389-1397. PubMed ID: 33888601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2.
    Ikeda Y; Taveira-DaSilva AM; Pacheco-Rodriguez G; Steagall WK; El-Chemaly S; Gochuico BR; May RM; Hathaway OM; Li S; Wang JA; Darling TN; Stylianou M; Moss J
    Am J Physiol Lung Cell Mol Physiol; 2011 Jan; 300(1):L64-72. PubMed ID: 21036916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.